Search
for
Sort by
Research 31–60 of 1000+
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Skin manifestations associated with COVID-19
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry
- 34941 Case report: Hair care routine to treat the telogen effluvium associated with post–COVID-19 infection
- Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
- [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
- Factors associated with readmission to the Emergency Department in a cohort of COVID-19 hospitalized patients
- Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
- Skin disorders associated with the COVID‐19 pandemic: A review
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Symmetrical drug‐related intertriginous and flexural exanthema like eruption associated with COVID‐19 vaccination
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- An increase in respiratory protection device injuries associated with the COVID-19 pandemic
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Cytokine profiles associated with persisting symptoms of post-acute sequelae of COVID-19
- Possibilities for correcting diffuse alopecia associated with prior coronavirus infection (COVID-19)
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Genetic correlation analysis does not associate male pattern baldness with COVID-19
- 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia (vol 35, pg e243, 2021)
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- - Pregnancy and postpartum maternal hair cortisol are associated with infant development during the COVID-19 pandemic